← Back to headlines
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline
Eli Lilly is reportedly considering re-entering the bidding process for Abivax, contingent on whether AstraZeneca fails to meet its acquisition deadline.
14 Mar, 03:30 — 14 Mar, 03:30
Sources
Showing 1 of 1 sources
